The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women

July 18, 2017 updated by: Katherine Brooke-Wavell, Loughborough University

Osteoarthritis (OA) and osteoporosis (OP) affect large numbers of the population. Around 8 million people in the UK are affected by OA and over 300,000 people present with fragility fractures in the UK each year. High impact exercise has been shown to improve markers of bone health but the effect of this exercise on the cartilage is less well understood. A six month, one leg, exercise program based on hopping will be carried out by a group of post-menopausal women. Post-menopausal women are particularly at risk from OP and the research should give information on the feasibility of this type of exercise program in this age group and the effect on cartilage. Participants will be aged between 55 and 70 (at least five years post menopause) with no conditions that would limit their ability to complete the exercise program.

To assess changes in participants' cartilage and bone properties they will be asked to attend several meetings at Loughborough University. Before and after the exercise program participants will have bone density scans and MRI scans of the knee joint. A subset (n=4) will undergo high resolution bone scans that can demonstrate changes in bone structure. The intervention is a home based exercise programme lasting approximately 10 minutes per day. Initially this will be individualised to each participant with the end goal being daily exercise sessions. The programme will last for six months with supervised sessions offered throughout the trial. Using an intervention affecting just one leg will allow the research team to use the other leg as a control.

The research team hypothesise that in a population of post-menopausal women, a six month, unilateral exercise intervention will improve bone mineral density at the proximal femur with no negative effects on articular cartilage.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The research is a 6 month, intervention study of unilateral (single limb) exercise with the changes in a randomly chosen exercise leg being compared to those in the other (control) leg.

Potential participants (women aged 55-70) will be approached via existing links in the community, at local community centres, through local media, posters and flyers. After initial contact to determine whether they meet the inclusion/exclusion criteria they will be invited to join the study and sent the participant information sheet (PIS). If they then wish to aid in the research they will be invited to a first meeting at Loughborough University.

At the initial meeting the participant can further discuss the project and PIS with the research team. If they fully understand the project and are happy to take part they will be invited to sign the informed consent form. At this stage each participant will be anonymised using a project code. Screening and baseline measurements will then be taken.

Screening questionnaires will be taken following consent to the study. These include a demographic questionnaire, health screen questionnaire, calcium intake questionnaire, physical activity readiness questionnaire (PAR-Q) and bone physical activity questionnaire (BPAQ).

Dual X-ray Absorptiometry (DXA) scans of the whole body, anterior-posterior (AP) spine and dual femur will be taken for each participant to give baseline measurements of bone mineral density.Standard positioning procedures for the measurement being taken will be utilised to allow the calculation of the T-score.

Functional tests will be performed to investigate hopping and balance ability. Unilateral balance will be analysed by measuring postural sway using a force platform. Participants will be asked to balance on one leg for up to 30 seconds. Amplitude of displacement will be calculated, this is the distance between the maximum and minimum centre of pressure (COP) in both directions. COP path length is the total distance travelled and will be calculated and divided by the trial time to give the COP velocity.

Maximal hop height will be measured by recording the vertical displacement of a marker placed on the lumbar spine of each participant whilst conducting a maximal hop. This will be repeated for each leg. The ground reaction force (GRF) of the maximal hop will be recorded using a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform a counter movement, maximal hop using their arms to help with propulsion and ensure maximal hop height. After one or two familiarisation attempts the participant will be asked to complete three maximal hops. Allowing for repeats if they do not land fully on the force platform. The peak GRF recorded from these three attempts will be used in the final analysis.

Ground reaction forces during a set of ten hops, which is the end goal of the exercise programme, will be recorded on a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform ten counter movement hops using their arms to help with propulsion if able. At the baseline measurements participants will be asked to perform ten hops to the best of their ability, with a rigid support available for them to lean on

A second appointment will be arranged to acquire baseline MRI scans of each knee joint. This will involve the safety checks, conversation with the radiographers and scan times of up to one hour.

Following the MRI scans the exercise leg will be randomly assigned using opaque envelopes. Each envelope will contain a note saying either 'left leg' or 'right leg'. The envelopes will be split into smaller subgroups of eight for minimisation. This will remove the possibility of the first half of volunteers choosing the same leg and removing the randomisation effect on the second half. Participants will be presented with a training diary and instructions on how to complete the exercise programme over six months. The first day of exercise will be completed with the research team at this appointment and the intervention considered started. This second meeting should last for approximately 90 minutes.

The required exercise lasts for no longer than 10 minutes each session and can be performed at home. The intervention will be personalised to the individual's ability and the frequency of the exercise will steadily increase as the participant improves, until the exercise is completed daily. Regular group sessions at Loughborough University will be offered to all participants. The exercise time will remain at ten minutes but the session will be longer, allowing for discussion and check-ups with participants. These will be weekly sessions for the first two months and then once a month for the remaining time.

Follow up measurements will take place six months after the commencement of the exercise programme. Repeat DXA, MRI and functional outcome tests will be carried out on all participants, following the same protocol as at baseline. Again this will occur over two meetings at Loughborough University.

A subset (n=4) will undergo high resolution bone scans (HR-pQCT) that can demonstrate changes in bone structure. This measurement will be taken at the distal tibia and lasts around three minutes per leg. Measurements will be taken pre and post the six month exercise intervention.

Descriptive statistics will be calculated to give information on mean values and variation (standard deviation) of the cohort. This will include age, height, body mass, BMI and time since last menstruation.

Using Levene's test when comparing the exercise to control leg and Mauchly's test of sphericity to compare from baseline to end of study, the variance of the data will be analysed. Normal distribution will be analysed using Shapiro-Wilks test and visual examination of Q-Q plot. If variance is shown to be homogenous and distribution normal within the population then a repeated measures analysis of variance (RM-ANOVA)will be used to detect any significant differences between leg (exercise versus control, time (baseline versus post-intervention) or leg x time interaction in the outcome variable described previously. If any of the outcome measures do not meet the assumptions to conduct parametric tests i.e. ANOVA then Kruskal-Wallis H test will be used to detect any significant change in differences.

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Leicestershire
      • Loughborough, Leicestershire, United Kingdom, LE11 3TU
        • Recruiting
        • Loughborough University
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Chris Hartley, MSc
        • Principal Investigator:
          • Katherine Brooke-Wavell, PhD
        • Sub-Investigator:
          • Jonathan Folland, PhD
        • Sub-Investigator:
          • Robert Kerslake

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Post-menopausal - at least 12 months since last menstruation and/or hysterectomy, oophorectomy or hormonal contraceptive use

Exclusion Criteria:

  • Existing knee, hip or back injury.
  • Any medical conditions or injuries which exclude participation in an exercise intervention e.g. heart conditions, hypertension
  • BMI > 30 kg/m2
  • Participation in a study involving ionising radiation in the previous 12 months.
  • Exercise involving ground reaction forces greater than that of jogging more than once a week.
  • Contraindications to MRI or DXA
  • Osteoporotic (FRAX score requiring the participant is advised to seek treatment)
  • Medication affecting bone metabolism or density

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Exercise Leg
Left or right leg randomly assigned as exercise leg in a unilateral, exercise intervention. This will be a progressive exercise programme with the aim being to complete 50 multidirectional hops completed daily. (Hopping)
A unilateral, hopping based exercise programme lasting six months.
No Intervention: Non exercise Leg
Randomly assigned non-exercise, control leg.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in T2 Relaxation Time (ms)
Time Frame: 6 months (pre and post intervention)
T2 mapping is an indicator of the water content in cartilage, with longer relaxation times a marker of cartilage degeneration
6 months (pre and post intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Femoral neck bone mineral density (g/cm2)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Femoral neck bone mineral content (g)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Spine bone mineral density (g/cm2)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Spine bone mineral content (g)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Postural sway (mm)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Maximal hop height (mm)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Ground Reaction force Maximal Hop (N)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Ground Reaction force for a set of ten hops (N)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in BMD(D100) (mg HA/cm3)
Time Frame: 6 months (pre and post intervention)
Volumetric Bone mineral density
6 months (pre and post intervention)
Change in Total bone mass (mg)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in BV/TV (%)
Time Frame: 6 months (pre and post intervention)
Percent bone volume
6 months (pre and post intervention)
Change in pBV/TV (%)
Time Frame: 6 months (pre and post intervention)
Plate bone volume fraction
6 months (pre and post intervention)
Change in rBV/TV (%)
Time Frame: 6 months (pre and post intervention)
Rod bone volume fraction
6 months (pre and post intervention)
Change in pBV/rBV (%)
Time Frame: 6 months (pre and post intervention)
Plate to - rod ratio
6 months (pre and post intervention)
Change in pBV/BV (%)
Time Frame: 6 months (pre and post intervention)
Plate tissue fraction
6 months (pre and post intervention)
Change in rBV/BV (%)
Time Frame: 6 months (pre and post intervention)
Rod tissue fraction
6 months (pre and post intervention)
Change in Bone surface(BS) (mm2)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in BS/TV (mm-1)
Time Frame: 6 months (pre and post intervention)
Bone surface density
6 months (pre and post intervention)
Change in Tb.Th (mm)
Time Frame: 6 months (pre and post intervention)
Trabecular thickness
6 months (pre and post intervention)
Change in Tb.Sp (mm)
Time Frame: 6 months (pre and post intervention)
Trabecular Separation
6 months (pre and post intervention)
Change in Tb.N (mm-1)
Time Frame: 6 months (pre and post intervention)
Trabecular number
6 months (pre and post intervention)
Change in Tb.Pf
Time Frame: 6 months (pre and post intervention)
Trabecular bone pattern (Tb.PF) follows the course of stress lines in the bone. This measurement indicates where the bone is under increased stress.
6 months (pre and post intervention)
Change in Conn.D (mm-3)
Time Frame: 6 months (pre and post intervention)
Connectivity density
6 months (pre and post intervention)
Change in DA
Time Frame: 6 months (pre and post intervention)
Degree of anisotropy
6 months (pre and post intervention)
Change in τ
Time Frame: 6 months (pre and post intervention)
Tortuosity (τ) is a measure of how well a structure can curve and bend easily. This is an indicator of where the most stress is on the bone structure.
6 months (pre and post intervention)
Change in SMI
Time Frame: 6 months (pre and post intervention)
Structural model index
6 months (pre and post intervention)
Change in BRV (mm3)
Time Frame: 6 months (pre and post intervention)
Bone resorption volume
6 months (pre and post intervention)
Change in BFV (mm3)
Time Frame: 6 months (pre and post intervention)
Bone formation volume
6 months (pre and post intervention)
Change in BRM (mg)
Time Frame: 6 months (pre and post intervention)
Bone resorption mass
6 months (pre and post intervention)
Change in BFM (mg)
Time Frame: 6 months (pre and post intervention)
Bone formation mass
6 months (pre and post intervention)
Change in BRF (%)
Time Frame: 6 months (pre and post intervention)
Bone resorption fraction
6 months (pre and post intervention)
Change in BFF(%)
Time Frame: 6 months (pre and post intervention)
Bone formation fraction
6 months (pre and post intervention)
Change in BRR(mm3/week)
Time Frame: 6 months (pre and post intervention)
Bone resorption rate
6 months (pre and post intervention)
Change in BFR(mm3/week)
Time Frame: 6 months (pre and post intervention)
Bone formation rate
6 months (pre and post intervention)
Change in Trabecular orientation distribution (Tb.O.D) (angle in degrees)
Time Frame: 6 months (pre and post intervention)
This is a measurement of the orientation of the trabeculae in the distal tibia relative to the central axis tibial shaft. The orientation can be categorised into transvers direction and longitudinal direction along the tibial shaft
6 months (pre and post intervention)
Change in Ct.Th(mm)
Time Frame: 6 months (pre and post intervention)
Cortical thickness
6 months (pre and post intervention)
Change in B.Po(%)
Time Frame: 6 months (pre and post intervention)
Bone porosity
6 months (pre and post intervention)
Change in Po.Dm(mm)
Time Frame: 6 months (pre and post intervention)
Pore diameter
6 months (pre and post intervention)
Change in Pore volume distribution
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Failure load (N)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Strain
Time Frame: 6 months (pre and post intervention)
This analyses the change in length of the bone over the time period, expressed as % change.
6 months (pre and post intervention)
Change in Stiffness (N/mm)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Young's Modulus (GPa)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Mechanical anisotropic ratio
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Strain energy density (J/m3)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)
Change in Strain gradient (με/mm)
Time Frame: 6 months (pre and post intervention)
6 months (pre and post intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine Brooke-Wavel, PhD, Loughborough University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Anticipated)

June 1, 2018

Study Completion (Anticipated)

January 1, 2019

Study Registration Dates

First Submitted

April 5, 2017

First Submitted That Met QC Criteria

July 18, 2017

First Posted (Actual)

July 21, 2017

Study Record Updates

Last Update Posted (Actual)

July 21, 2017

Last Update Submitted That Met QC Criteria

July 18, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

There is a plan to have scans available on a public database.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Subscribe